Select an enzyme substrate only after confirming that the reaction, reader, assay matrix and operating schedule work together. A stronger enzyme-only signal is useful screening information, but it is not sufficient evidence of better analyte detection.
Use the questions below to build a candidate record. For each item, record the answer, the supporting experiment or document, and any unresolved condition. Eliminate incompatible candidates first, then compare the performance of the remaining systems in the complete immunoassay.
Confirm the enzyme, substrate and measured product
Begin with the actual conjugate, not only the enzyme name. Record its preparation, working amount and the formulation that can reach the reporter reaction. A substrate that works with unconjugated enzyme under favorable conditions still needs testing with the final conjugate.
| Checklist question | Evidence to record | Decision consequence |
|---|---|---|
| Does the enzyme act on the intended substrate? | Reaction identity and a controlled test with the intended conjugate. | Resolve an enzyme-trigger mismatch before optimizing signal. |
| Are required reaction components present? | Buffer, pH, cofactors or cosubstrates, and preparation sequence. | Evaluate the full formulation rather than a substrate name alone. |
| What product will be measured? | Absorbing, fluorescent, light-emitting or deposited product under the final conditions. | Confirm that the output fits the selected measurement mode. |
| Does stopping change the measured species? | Endpoint chemistry and the reading conditions after stopping, if used. | Do not transfer settings between stopped and unstopped methods without verification. |
| Must the product remain at a capture site? | Product localization in the intended membrane or surface geometry. | Reject a candidate that loses the spatial signal required by the assay. |
Horseradish peroxidase (HRP) and alkaline phosphatase (ALP) require different reactions. The IUBMB entry for ALP describes phosphate monoester hydrolysis. Bronstein and colleagues demonstrated dioxetane substrates with different triggering groups for ALP and beta-galactosidase. A shared light-emitting scaffold therefore does not imply enzyme interchangeability.
For tetramethylbenzidine, or TMB, Josephy and colleagues characterized different oxidation species and their behavior under acidic conditions. This is why the method must specify the product state being read. The checklist does not prescribe an acid concentration, stopping reagent or wavelength for every formulation.
For broader background before screening, consult the enzyme-label comparison. Record a candidate as unresolved if its chemistry is insufficiently specified; an impressive signal does not remove that information gap.
Match the reader and the complete timing sequence
List the available measurement mode and settings before selecting a substrate. Absorbance, fluorescence and chemiluminescence require different optical arrangements. The detection-mode comparison explains these differences; this checklist turns them into a record for the specific instrument.
- Optical compatibility: Record the measurement wavelength or spectral range, filters where relevant, vessel or membrane, and reading geometry.
- Acquisition settings: Record integration time, gain or exposure where applicable, and how saturation is recognized.
- Reaction schedule: Record substrate addition, mixing, delay, development and the acquisition interval.
- Batch consistency: Compare the earliest and latest positions in the intended dispensing and reading order.
- Endpoint behavior: If stopping is used, establish the interval during which the stopped response remains suitable for measurement.
- Spatial isolation: Check whether a strong neighboring well or region affects the result being measured.

Dotsikas and Loukas showed that enhancer selection could change chemiluminescence intensity and kinetics together. A candidate ranked at one delay may therefore behave differently under another acquisition schedule. Preserve the timing record with the result, and compare candidates under the workflow they would actually use.
Decide whether the screening experiment holds settings constant or allows each candidate an optimized method. Both approaches can be informative, but they answer different questions. A fixed-setting comparison tests compatibility with an existing method; separately optimized candidates compare complete methods and their operating demands.
Do not compare raw light or fluorescence units across instruments as though they were a common analyte scale. Use calibration, blanks and the relevant performance criteria for each method. Treat a reader change as a reason to verify the selection again.
Require evidence from the complete assay
Start with an enzyme-only comparison to identify gross incompatibility, then move to the full binding, washing and reporter sequence. Include the substrate blank and appropriate assay blanks. A clean substrate solution can still produce a high assay background when active label is retained nonspecifically.
| Checklist question | Comparison to include | Interpretation |
|---|---|---|
| Are blanks low and consistent? | Replicate reagent and assay blanks across relevant runs. | Review spread as well as the mean; one low blank is insufficient. |
| Are low-level samples distinguishable? | Relevant low-analyte material measured with the complete method. | Enzyme detection does not establish analyte detection capability. |
| Is the required range usable? | Samples spanning the intended working range, including high response. | Check calibration behavior and saturation rather than brightness alone. |
| Does the matrix alter the outcome? | Representative specimens or justified matrix materials alongside controlled references. | Good performance in buffer cannot automatically be transferred to specimens. |
| Is performance reproducible? | Relevant reagent lots, days, operators or instruments according to intended use. | Choose acceptable variability, not only the best individual run. |
Keep limit of blank, limit of detection and limit of quantitation distinct. The public scope of CLSI EP17 addresses these different detection-capability questions. A substrate screen can identify promising conditions, but it does not by itself establish a formal claim under that guideline.
Define the intended measurement requirement before ranking candidates. A method intended to quantify low concentrations needs evidence of suitable quantitative performance there, not merely a visible response above background. Record the acceptance criteria and analysis method before reviewing the comparison.
When an apparent improvement is confined to selected specimens, investigate the mechanism rather than adjusting the cutoff to hide it. Consider an enzyme-only compatibility check, appropriate omission controls and specimen comparisons. Changing the substrate may alter reporter chemistry while leaving a binding interference intact.
Check preparation, storage and practical use
The selected candidate is a reagent system with a handling procedure. Record whether it is ready to use, mixed immediately before use or reconstituted from a dried presentation. Evaluate the procedure that the intended operator can perform consistently.
- Preparation: Are mixing order, water or diluent quality, volumes and equilibration conditions specified?
- Working life: Does prepared substrate retain acceptable blank and positive response throughout the proposed use period?
- Packaging: Have the intended container, light exposure and opening pattern been included in the evaluation?
- Stored components: Are enzyme conjugate and substrate assessed separately where needed to identify the source of drift?
- Device integration: For a strip or cartridge, can substrate reach the reaction region reproducibly after storage?
- Operational fit: Are additional dispensing, washing, stopping or reader steps compatible with the setting?
- Material controls: Are identity, formulation version, lot information and applicable handling instructions available?
Test the actual candidate formulation rather than assuming that two reagents sharing a named substrate have the same behavior. Differences in supporting components can change background, kinetics and storage performance. The chemiluminescent substrate guide gives examples of why this matters for light-based methods.
When a conjugate or substrate is replaced during a stability comparison, document the substitution. Otherwise, the study may unintentionally compare two changing components at once. Keep the selected reaction and handling method sufficiently specified that another operator can reproduce the comparison.
Close the selection with a short evidence record

Use a narrative decision supported by the checklist, rather than an arbitrary numerical score that allows a serious incompatibility to be offset by a bright signal. A missing reader mode or incompatible enzyme trigger must be resolved before a candidate can be selected.
- Name the candidate and method: identify the formulation version, conjugate, assay format and reader settings.
- State the requirement: summarize the intended range, matrix, timing and handling constraints.
- Summarize the evidence: reference the compatibility, blank, low-level, range, precision and storage comparisons.
- Record the decision: select the candidate, retain it for further work or reject it, with the specific reason.
- List open items: identify missing evidence and the experiment needed to resolve each item.
- Define retest triggers: include changes to conjugate, substrate formulation, surface, matrix, timing, packaging or reader that could affect performance.
Before closing the record, confirm that the chosen method still meets the requirement under routine conditions rather than only the most favorable experiment. Keep exceptions visible and distinguish demonstrated performance from proposed future claims.
This checklist supports a structured development decision. It does not validate a diagnostic test or establish clinical performance. Return to the immunoassay signal guide collection when an unresolved item needs deeper investigation.
Sources and further reading
- Josephy PD, Eling T, Mason RP. The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. Free radical and charge-transfer complex intermediates. Journal of Biological Chemistry. 1982;257:3669–3675.
- International Union of Biochemistry and Molecular Biology. EC 3.1.3.1: Alkaline phosphatase. Enzyme nomenclature entry; accessed 2026-09-24.
- Bronstein I, Edwards B, Voyta JC. 1,2-dioxetanes: novel chemiluminescent enzyme substrates. Applications to immunoassays. Journal of Bioluminescence and Chemiluminescence. 1989;4:99–111. DOI: 10.1002/bio.1170040116.
- Dotsikas Y, Loukas YL. Effect of the luminol signal enhancer selection on the curve parameters of an immunoassay and the chemiluminescence intensity and kinetics. Talanta. 2007;71:906–910. DOI: 10.1016/j.talanta.2006.05.068.
- Clinical and Laboratory Standards Institute. EP17: Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures. Second edition. 2012; official public scope accessed 2026-09-24.